S
Spiration
Developer of therapeutic medical devices for the treatment of air leaks and lung diseases
About Spiration
Spiration Inc. specializes in medical devices designed to improve lung function in patients suffering from severe emphysema and prolonged air leaks. The company's flagship product, the Spiration Valve, is a small, umbrella-shaped, one-way valve that is placed inside the airways of a lung. This device helps to redirect air from the less healthy to the more healthy parts of the lung, reducing overinflation and allowing trapped air and fluids to escape. This results in the healthier parts of the lung expanding and functioning more normally, thereby improving overall lung health.
Spiration operates in the medical device market, primarily serving healthcare providers and patients across Western and Eastern Europe, as well as the Americas. The company's business model revolves around the development, approval, and distribution of its proprietary valve system. Revenue is generated through the sale of these medical devices to hospitals and clinics, as well as through partnerships and licensing agreements.
The Spiration Valve has received FDA approval for the treatment of severe emphysema and has been FDA approved since 2008 for the management of prolonged air leaks. This regulatory approval underscores the device's efficacy and safety, making it a trusted solution for healthcare providers.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 1999
- Headquarters
- Kenmore, United States
- Employees
- 35
- Open positions
- None listed
- Dealroom signal
- 68.4/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Biomedical, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | Jun 2010 | $0 | — | Olympus | ↗ |
| DEBTDebt | Apr 2010 | $6.5M | — | Undisclosed | — |
Growth signals
Latest recorded traffic for Spiration is 290 monthly website visits, up 107.1% over the last three months. Spiration's team declined 20.5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later6 investors entered at this stage
NEA
Three Arch Partners
Versant Ventures
Sprout Group
New Leaf Venture Partners
InterWest Partners
Other known investors1 additional known investor
Olympus
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Spiration on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Spiration’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







